A Comparative Study of the Respiratory Neonatal Outcomes Utilizing Dexamethasone Sodium Phosphate versus a Mixture of Betamethasone Dipropionate and Betamethasone Sodium Phosphate as an Antenatal Corticosteroid Therapy (original ) (raw )Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants
Giuseppe Del Vento
Intensive Care Medicine, 1999
View PDFchevron_right
Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy
Yuh-jyh Lin
Pediatric Pulmonology, 1999
View PDFchevron_right
A case-control study on the effects of incomplete, one, and more than one dexamethasone course on acute respiratory problems in preterm neonates born between 280 and 366 weeks of gestation
Saifon Chawanpaiboon
BMC Pregnancy and Childbirth
View PDFchevron_right
Does the Use of Antenatal Corticosteroids Reduce Respiratory Morbidity in Babies Born in Late Preterm Period?
fatimat akinlusi
Research Square (Research Square), 2023
View PDFchevron_right
Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth
Philippa Middleton
Cochrane Database of Systematic Reviews, 2007
View PDFchevron_right
Temporal trends of the use of dexamethasone for the treatment of bronchopulmonary dysplasia in very low-birth- weight preterm infants: a single-center evaluation
Journal einstein (São Paulo)
einstein (São Paulo), 2024
View PDFchevron_right
Effects of Antenatal Dexamethasone on Respiratory Distress in Late Preterm Infant: a randomized controlled trial
nipawan attawattanakul
Thai Journal of Obstetrics and Gynaecology, 2015
View PDFchevron_right
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Tsu F Yeh
PEDIATRICS, 1998
View PDFchevron_right
Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials
Martin Offringa
Pediatrics, 2009
View PDFchevron_right
Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm
Janet Peacock
PloS one, 2017
View PDFchevron_right
A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity
David Odd
Journal of Paediatrics and Child Health, 2004
View PDFchevron_right
Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants
Barbara Mettelman
The Journal of Pediatrics, 2019
View PDFchevron_right
Effectiveness of Antenatal Dexamethasone in Reducing Respiratory Distress Syndrome and Mortality in Preterm Neonates: a Nested Case Control Study
Ritah F Mutagonda
View PDFchevron_right
Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
Shraga Blazer
Archives of Disease in Childhood - Fetal and Neonatal Edition, 1996
View PDFchevron_right
Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome
TF Fok , Myrna Dolovich
Archives of Disease in …, 1999
View PDFchevron_right
The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: A two-year follow-up study
Wen-hui Tsai
Acta Paediatrica, 2005
View PDFchevron_right
Effect of Antenatal Dexamethasone on Respiratory Distress in Late Preterm Infants: Results from the First Vietnamese Matched Cohort Study
Minh Tam Le
2021
View PDFchevron_right
Relationship of Time Interval between Antenatal Corticosteroid Administrations to Delivery with Respiratory Distress in Preterm Newborns
lavanya rai
International Journal of Infertility & Fetal Medicine, 2015
View PDFchevron_right
Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and
Wes Onland
2000
View PDFchevron_right
European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants – 2010 Update
Komang Purnamaningsih
Neonatology, 2010
View PDFchevron_right
Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis
Wes Onland
PEDIATRICS, 2008
View PDFchevron_right
Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial
Melania Amorim
BMJ, 2011
View PDFchevron_right
Postnatal Corticosteroid to Prevent or Treat Chronic Lung Disease in Preterm Infants
suma pyati
2010
View PDFchevron_right
Update on prenatal steroid for prevention of respiratory distress
Glen Aylward
American Journal of Obstetrics and Gynecology, 1986
View PDFchevron_right
Antenatal use of Corticosteroids to Prevent Respiratory Insufficiency in Preterm Babies
M S SREELAKSHMI
Asian Journal of Pharmaceutical Education and Research, 2020
View PDFchevron_right
European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update
Ola Saugstad
Neonatology, 2013
View PDFchevron_right
Antenatal dexamethasone use and respiratory distress in late preterm infants: results from first Vietnamese matched cohort study
Vu Quoc Huy Nguyen
BMC Pregnancy and Childbirth
View PDFchevron_right